Search results for "Hospitalization"

showing 10 items of 463 documents

The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry

2021

Abstract Background Knowledge on the main clinical and prognostic characteristics of older multimorbid subjects with liver cirrhosis (LC) admitted to acute medical wards is scarce. Objectives To estimate the prevalence of LC among older patients admitted to acute medical wards and to assess the main clinical characteristics of LC along with its association with major clinical outcomes and to explore the possibility that well-distinguished phenotypic profiles of LC have classificatory and prognostic properties. Methods A cohort of 6,193 older subjects hospitalised between 2010 and 2018 and included in the REPOSI registry was analysed. Results LC was diagnosed in 315 patients (5%). LC was ass…

Patient Discharge.RegistrieAgingmedicine.medical_specialtyCirrhosisphenotypeliver cirrhosisAftercareOlder populationNOolder people03 medical and health sciencesSocial support0302 clinical medicinePhenotypic analysisOlder patientsInternal medicinemedicineHumansRegistries030212 general & internal medicineLS4_4Hospital MortalityAgedbusiness.industryhospitalisationliver cirrhosiHazard ratioConfoundingphenotypesGeneral Medicinemedicine.diseasedisability; hospitalisation; liver cirrhosis; mortality; older people; phenotypes; Aged; Hospital Mortality; Hospitalization; Humans; Liver Cirrhosis; Registries; Aftercare; Patient DischargemortalityPatient DischargeHospitalizationdisabilityCohortdisability hospitalisation liver cirrhosis mortality older people phenotypes030211 gastroenterology & hepatologyGeriatrics and Gerontologybusinessdisability; hospitalisation; liver cirrhosis; mortality; older people; phenotypesHuman
researchProduct

Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infants

2014

Acute bronchiolitis is the leading cause of lower respiratory t ract infection and hospitalization in children less than 1y ear of age worldwide. It is usually a mild disease, but some children may develop severe symptoms, requiring hospital admission and ventilatory support in the ICU. Infants with pre-existing risk factors (prematurity, bronchopulmonary dysplasia, congenital heart diseases and immunodeficiency) may be predisposed to a severe form of the disease. Clinical diagnosis of bronchiolitis is manly based on medical history and physical examination (rhinorrhea, cough, crackles, wheezing and signs of respiratory distress). Etiological diagnosis, with antigen or genome detection to i…

PediatricsBronchiolitis; Bronchopulmonary dysplasia; Congenital heart diseases; Immunodeficiency; Oxygen therapy; Prematurity; Prevention; Prophylaxis; Respiratory syncytial virus;ReviewRespiratory syncytial virusSeverity of Illness IndexCongenital heart diseasesSettore MED/38 - Pediatria Generale E SpecialisticaAdrenergic beta-2 Receptor AntagonistsVitamin DChildrenRespiratory distressVitaminsEnvironmental exposurePatient DischargeAnti-Bacterial AgentsBronchodilator AgentsHospitalizationSettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICABronchiolitisbronchiolitisPrematuritymedicine.drugPalivizumabRespiratory Therapymedicine.medical_specialtyEpinephrineDecision MakingAntibodies Monoclonal HumanizedAntiviral AgentsIntensive Care Units NeonatalBronchiolitis Respiratory syncytial virus Prematurity Bronchopulmonary dysplasia Congenital heart diseases Immunodeficiency Oxygen therapy Prevention ProphylaxismedicineHumansImmunodeficiencyAcute bronchiolitisMedical historyConsensus DocumentIntensive care medicineGlucocorticoidsPalivizumabAsthmaSaline Solution HypertonicPrimary Health CareProphylaxisbusiness.industryNebulizers and VaporizersPreventionInfant NewbornOxygen Inhalation TherapyHumidityEnvironmental ExposureAcute bronchiolitis Consensus Documentmedicine.diseaseBronchopulmonary dysplasiaOxygen therapyHypertonic salineBronchopulmonary dysplasiaBronchiolitisbusinessItalian Journal of Pediatrics
researchProduct

Temporal Trends in the Prevalence of Infective Endocarditis in Germany Between 2005 and 2014

2016

Infective endocarditis (IE) is a potentially life-threatening disease. Little is known about temporal trends in its prevalence in Germany. In 2009, recommendations for antibiotic prophylaxis were deescalated in the revised European Society of Cardiology guideline to include only patients at high risk of IE. We selected patients with the discharge diagnosis of IE based on the International Classification of Diseases code I33 in the nationwide database of the Federal Statistical Office of Germany. We identified 94,364 patients with a diagnosis of IE from January 2005 to December 2014. Mean prevalence was 11.6 per 100,000 citizens per year in this 10-year-period. The annual IE prevalence showe…

Pediatricsmedicine.medical_specialtyEndocarditisbusiness.industryNationwide databaseGuidelineDisease030204 cardiovascular system & hematologymedicine.diseaseConfidence intervalHospitalization03 medical and health sciences0302 clinical medicineGermanyInfective endocarditisCase fatality ratePrevalenceHumansMedicineEndocarditis030212 general & internal medicineAntibiotic prophylaxisCardiology and Cardiovascular MedicinebusinessThe American Journal of Cardiology
researchProduct

Varicella vaccination as useful strategy for reducing the risk of varicella-related hospitalizations in both vaccinated and unvaccinated cohorts (Ita…

2020

The present study summarizes evidences of the impact that varicella vaccination (VV) introduction and coverage can have on varicella attributable hospitalization rates.A retrospective observational study was carried out by considering hospital discharge records and VV coverage at 24 months collected from 2003 to 2018 by the Italian Ministry of Health. All hospitalizations records reporting an ICD-9 CM 052.X code as the principal diagnosis or any of the five secondary diagnoses were considered as related to varicella. The hospitalization rate reduction was evaluated by calculating average annual percent change (AAPC) through joint-point analysis.Hospitalization rates showed a decreasing tren…

Pediatricsmedicine.medical_specialtyHerpesvirus 3 Human030231 tropical medicineVaricella vaccinationChickenpox Vaccine03 medical and health sciences0302 clinical medicineChickenpoxmedicineHospital dischargeHumans030212 general & internal medicineChildAgedGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryPublic healthVaccinationPublic Health Environmental and Occupational HealthInfantRetrospective cohort studyAnnual Percent ChangeVaccinationHospitalizationInfectious DiseasesItalyMolecular MedicineChristian ministryPrincipal diagnosisbusinessVaricella vaccination.Vaccine
researchProduct

Impact of universal vaccination against varicella in Italy: Experiences from eight Italian Regions.

2014

In Italy, the introduction of Universal Varicella Vaccination (UVV) has been decided but postponed, as a national programme, until 2015, when data from Regions which have already implemented it will be available. Starting from 2003, eight Italian Regions (Basilicata, Calabria, Friuli Venezia Giulia, Apulia, Sardinia, Sicily, Tuscany and Veneto) have progressively introduced UVV, in their immunization programme, with different schedules in children aged 13-15 months and 5-6 years, currently a two-dose schedule is adopted by all Regions. In June 2013, an Interregional Group on Varicella Vaccination (IGVV) has been established in order to assess the effectiveness of varicella vaccination with …

Pediatricsmedicine.medical_specialtyImmunologyadverse events following varicella immunizationVaricellaSettore MED/42 - Igiene Generale E ApplicataEnvironmental healthmedicineImmunology and AllergyHealth policyChickenpox VaccinePharmacologyChickenpoxbusiness.industryIncidence (epidemiology)immunization coverageHealth services researchUniversal Varicella VaccinationnotificationsVaricella; Universal Varicella Vaccination; Notifications; Hospitalizations; Immunization coverage; Adverse effectsmedicine.diseaseVaccinationImmunizationVaccination coverageUniversal Varicella Vaccination; Varicella; adverse events following varicella immunization; hospitalizations; immunization coverage; notificationsbusinesshospitalization
researchProduct

Epidemiological assessment of Respiratory Syncytial Virus infection in hospitalized infants, during the season 2005–2006 in Palermo, Italy

2009

Abstract Objectives Respiratory Syncytial Virus (RSV) is the leading cause of hospitalization for lower respiratory tract infections (LRTI) in young children worldwide. We evaluate the epidemiological and clinical patterns of RSV infection in infants hospitalized for LRTI in in Palermo, South Italy, Sicily. Methods We collected the demographic details of infants hospitalized to G. Di Cristina Children's Hospital in Palermo for LRTI between November 2005 and May 2006. We also included all cases occurred in newborns hospitalized in the Neonatal Intensive Care Unit (NICU) Of Palermo. Results During the studied period, 335/705 hospitalized infants for LRTI were enrolled in the study. The trend …

Pediatricsmedicine.medical_specialtyNeonatal intensive care unitSettore MED/17 - Malattie InfettiveRespiratory tract infectionsMaternal and child healthbusiness.industryvirusesResearchlcsh:RJ1-570Infantlcsh:Pediatricsmedicine.diseaseVirusrespiratory tract diseasesHospitalizationLower Respiratory Tract InfectionLower respiratory tract infectionEpidemiologymedicineRespiratory Syncytial VirusRespiratory systembusinessItalian Journal of Pediatrics
researchProduct

Neonatal problems of late and moderate preterm infants.

2012

International audience; Late and moderate preterm infants account for \textgreater80% of premature births. These newborns experience considerable mortality and morbidity in comparison with full-term born infants. The purpose of this paper is to summarise the most common morbidities of late and moderate preterm infants in the neonatal period, their incidence, severity, risk factors and need for admission to the different levels of care. The recent findings on preventive strategies and management priorities for clinical care of these vulnerable babies are also reviewed.

Pediatricsmedicine.medical_specialty[ SDV.MHEP.PED ] Life Sciences [q-bio]/Human health and pathology/PediatricsDiseasesGestational AgeInfant Premature Diseases03 medical and health sciences0302 clinical medicinePregnancyRisk Factors030225 pediatricsNeonatalIntensive Care Units NeonatalmedicineHumans030212 general & internal medicineClinical carePrematurePregnancy[SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/PediatricsObstetricsbusiness.industryIncidence (epidemiology)IncidenceInfant NewbornGestational ageInfantJaundicemedicine.diseaseNewbornInfant newborn3. Good healthHospitalizationIntensive Care UnitsPediatrics Perinatology and Child HealthFemalemedicine.symptombusinessInfant PrematureSeminars in fetalneonatal medicine
researchProduct

Paediatric acute rheumatic fever in developed countries: Neglected or negligible disease? Results from an observational study in Lombardy (Italy)

2018

Introduction: Acute Rheumatic Fever (ARF) is a multisystemic disease that results from an autoimmune reaction due to group A streptococcal infection. The disease affects predominantly children aged 5 to 15 years and although its incidence in developed Countries declined since the early 1900s, to date there is a paucity of data that confirm this epidemiological trend. Objective: The study aimed to assess the burden of ARF in term of hospitalization and to describe the characteristics of acute rheumatic fever (ARF) in the paediatric population of Lombardy. Study design: The study was carried out by analyzing hospital discharge records of patients resident of Lombardy and aged 0–17 years old w…

Pediatricsmedicine.medical_specialtypaediatricDisease030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicinechildrenGroup A streptococcal infectionEpidemiologymedicine030212 general & internal medicineacute rheumatic fever| epidemiology| hospitalization| children| adolescent| paediatric| Italybusiness.industrylcsh:Public aspects of medicineIncidence (epidemiology)lcsh:RA1-1270Acute rheumatic feverGeneral MedicineEvidence-based medicinemedicine.diseaseacute rheumatic feverItalyadolescentepidemiologyObservational studybusinessDeveloped countryResearch ArticlehospitalizationAIMS Public Health
researchProduct

Differences in Long-COVID Symptoms between Vaccinated and Non-Vaccinated (BNT162b2 Vaccine) Hospitalized COVID-19 Survivors Infected with the Delta V…

2022

This study compared differences in the presence of post-COVID symptoms among vaccinated and non-vaccinated COVID-19 survivors requiring hospitalization due to the Delta (B.1.617.2) variant. This cohort study included hospitalized subjects who had survived SARS-CoV-2 infection (Delta variant) from July to August 2021 in an urban hospital in Madrid, Spain. Individuals were classified as vaccinated if they received full administration (i.e., two doses) of BNT162b2 (“Pfizer-BioNTech”) vaccines. Other vaccines were excluded. Those with just one dose of the BNT162b2 vaccine were considered as non-vaccinated. Patients were scheduled for a telephone interview at a follow-up around six months after …

PharmacologyInfectious DiseasesDrug DiscoveryImmunologyCOVID-19; vaccine; post-COVID; Delta; hospitalizationPharmacology (medical)Vaccines
researchProduct

Rate of hospitalizations and mortality of Respiratory Syncytial Virus infection compared to influenza in older people: a systematic review and meta-a…

2022

Respiratory Syncytial Virus (RSV) is commonly regarded as an infection typical of children, but increasing literature is showing its importance in older people. Since the data regarding the impact of RSV are still limited for older people, the aim of this systematic review and meta-analysis is to compare the rate of hospitalization and mortality between RSV and influenza in this population. A systematic literature search until 15 June 2022 was done across several databases and including studies reporting incidence rate and cumulative incidence of hospitalization and mortality in RSV and influenza affecting older people. Among 2295 records initially screened, 16 studies including 762,084 old…

PharmacologyInfectious DiseasesDrug DiscoveryImmunologymortality.Pharmacology (medical)Respiratory Syncytial Viruinfluenzameta-analysihospitalization
researchProduct